Akebia Therapeutics (NasdaqCM:AKBA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAshleigh Acker - Biotechnology Equity Research AssociateErik Ostrowski - CFO and Chief Business OfficerJohn Butler - President, CEO, and DirectorMercedes Carrasco - Senior Director of Investor and Corporate CommunicationsNicholas Grund - Chief Commercial OfficerSteven Burke - Chief Medical OfficerConference Call ParticipantsJulian Harrison - Managing Director and Biotechnology AnalystMichael Cherny - ...

Butterfly Network (NYSE:BFLY) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsJohn Doherty - EVP and CFOJoseph DeVivo - Chairman and CEOJosh Jennings - Managing DirectorConference Call ParticipantsAndrew Brackmann - Equity Research AnalystBen Haynor - Senior Research AnalystChase Knickerbocker - Senior Equity Research AnalystOperatorHello, everyone, thank you for joining the Butterfly Network Inc. Q4 and FY 2025 earnings call. My name is Gabrielle, I will be coordinating your call to ...

BeOne Medicines (NasdaqGS:BGNE) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAaron Rosenberg - CFOAmit Aggarwal - Chief Medical Officer of HematologyDan Maller - VP of Investor RelationsJohn V. Oyler - Co-Founder, Chairman and CEOLai Wang - President and Global Head of Research & DevelopmentMark Lanasa - SVP and Chief Medical OfficerMatt Shaulis - General Manager of North AmericaSean Laaman - Executive DirectorXiaobin Wu - President and COOZhihong Chen - Managing DirectorNone - Co ...

Stellantis (NYSE:STLA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAntonio Filosa - CEOEd Ditmire - SVP of Investor RelationsEmmanuel Rosner - Managing DirectorHenning Cosman - European Head of Automotive ResearchHorst Schneider - Head of European Automotive ResearchJoao Laranjo - CFOJosé Asumendi - Head of Global Autos and European Autos Equity ResearchMike Tyndall - DirectorPatrick Hummel - Head of European Autos ResearchPhilippe Houchois - Managing DirectorStuart Pearson - Hea ...

Akebia Therapeutics (NasdaqCM:AKBA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsErik Ostrowski - CFO and Chief Business OfficerJohn Butler - President, CEO, and DirectorMercedes Carrasco - Senior Director of Investor and Corporate CommunicationsNicholas Grund - Chief Commercial OfficerSteven K. Burke - Senior Vice President, Chief Research and Development OfficerConference Call ParticipantsJulian Harrison - Managing Director and Biotechnology AnalystManagi Nassar - Senior Equity ...

Papa John’s International (NasdaqGS:PZZA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsHeather Hollander - SVP, Finance and Corporate ControllerRavi Thanawala - CFO and President, North AmericaTodd Penegor - President and CEOConference Call ParticipantsBrian Bittner - Managing Director and Senior AnalystIsiah Austin - Equity Research AnalystJim Sanderson - Managing Director and Research AnalystTodd Brooks - Equity Research AnalystOperatorHello. Thank you for standing by. Welcome t ...

Shake Shack (NYSE:SHAK) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAlison Sternberg - Head of Investor RelationsAndy Barish - Managing DirectorKerry Britton - VP of Financial Planning and AnalysisPeter Saleh - Managing DirectorRob Lynch - CEOSamantha Chiang - Equity Research AssociateConference Call ParticipantsAnisha Dattani - Operations Analyst Team LeadBrian Vaccaro - Managing Director and Equity Research AnalystNick Setyan - Managing Director and Equity Research AnalystRahul ...

Privia Health Group (NasdaqGS:PRVA) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAndrew Mok - Director of Equity ResearchDavid Larsen - Managing DirectorDavid Mountcastle - EVP and CFOJailendra Singh - Managing DirectorJenny Shen - Equity Research AssociateLisa Gill - Managing DirectorMatthew Shea - VP of Equity ResearchParth Mehrotra - CEORobert Borchert - SVP of Investor and Corporate CommunicationsRyan Halstead - Managing Director of Equity ResearchConference Call ParticipantsA ...

BeOne Medicines (NasdaqGS:BGNE) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsAaron Rosenberg - CFOAmit Aggarwal - Chief Medical Officer of HematologyDan Maller - VP of Investor RelationsJohn V. Oyler - Co-Founder, Chairman and CEOLai Wang - President and Global Head of Research & DevelopmentMark Lanasa - SVP and Chief Medical OfficerMatt Shaulis - General Manager of North AmericaSean Laaman - Executive DirectorXiaobin Wu - President and COOZhihong Chen - Managing DirectorNone - Co ...

Collegium Pharmaceutical (NasdaqGS:COLL) Q4 2025 Earnings call February 26, 2026 08:00 AM ET Company ParticipantsBrandon Folkes - Managing DirectorColleen Tupper - CFOIan Karp - Head of Investor RelationsJeevan Larson - Equity Research AssociateScott Dreyer - Chief Commercial OfficerVikram Karnani - President and CEOConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystOperatorGreetings! Welcome to the Collegium Pharmaceutical fourth quarter and full year 2025 earnings co ...